Because heterozygosity for URAT1 mutants is much more common than homozygous or compound heterozygous loss-of-function states in the population and is associated with potential risks of kidney damage and renal calculi, clinicians should bear in mind that such individuals are relatively common, especially in Japanese, Korean, and Romani people. Here, SLC22A12 is linked to nephrolithiasis.